These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 19088492)

  • 1. Impact of gene-gender effects of adrenergic polymorphisms on hypothalamic-pituitary-adrenal axis activity in depressed patients.
    Haefner S; Baghai TC; Schule C; Eser D; Spraul M; Zill P; Rupprecht R; Bondy B
    Neuropsychobiology; 2008; 58(3-4):154-62. PubMed ID: 19088492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity.
    Kaestner F; Hettich M; Peters M; Sibrowski W; Hetzel G; Ponath G; Arolt V; Cassens U; Rothermundt M
    J Affect Disord; 2005 Aug; 87(2-3):305-11. PubMed ID: 15951024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression.
    Young EA; Abelson JL; Cameron OG
    Biol Psychiatry; 2004 Jul; 56(2):113-20. PubMed ID: 15231443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
    Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
    Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
    Papiol S; Arias B; Gastó C; Gutiérrez B; Catalán R; Fañanás L
    J Affect Disord; 2007 Dec; 104(1-3):83-90. PubMed ID: 17467808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients.
    Schüle C; Zill P; Baghai TC; Eser D; Zwanzger P; Wenig N; Rupprecht R; Bondy B
    Psychoneuroendocrinology; 2006 Sep; 31(8):1019-25. PubMed ID: 16890377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from recurrent major depression.
    Ahrens T; Deuschle M; Krumm B; van der Pompe G; den Boer JA; Lederbogen F
    Psychosom Med; 2008 May; 70(4):461-7. PubMed ID: 18378864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimentally challenged reactivity of the hypothalamic pituitary adrenal axis in patients with recently diagnosed rheumatoid arthritis.
    Dekkers JC; Geenen R; Godaert GL; Glaudemans KA; Lafeber FP; van Doornen LJ; Bijlsma JW
    J Rheumatol; 2001 Jul; 28(7):1496-504. PubMed ID: 11469453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica.
    Cutolo M; Foppiani L; Minuto F
    J Endocrinol Invest; 2002; 25(10 Suppl):19-23. PubMed ID: 12508908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex specific associations between common glucocorticoid receptor gene variants and hypothalamus-pituitary-adrenal axis responses to psychosocial stress.
    Kumsta R; Entringer S; Koper JW; van Rossum EF; Hellhammer DH; Wüst S
    Biol Psychiatry; 2007 Oct; 62(8):863-9. PubMed ID: 17716631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrinological mechanisms of actions of antidepressant drugs.
    Schüle C
    J Neuroendocrinol; 2007 Mar; 19(3):213-26. PubMed ID: 17280595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Process irregularity of cortisol and adrenocorticotropin secretion in men with major depressive disorder.
    Posener JA; Charles DeBattista ; Veldhuis JD; Province MA; Williams GH; Schatzberg AF
    Psychoneuroendocrinology; 2004 Oct; 29(9):1129-37. PubMed ID: 15219636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
    Aihara M; Ida I; Yuuki N; Oshima A; Kumano H; Takahashi K; Fukuda M; Oriuchi N; Endo K; Matsuda H; Mikuni M
    Psychiatry Res; 2007 Aug; 155(3):245-56. PubMed ID: 17587554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined dexamethasone/CRF test in remitted outpatients with recurrent major depressive disorder.
    Van Den Eede F; Van den Bossche B; Hulstijn W; Sabbe BG; Cosyns P; Claes SJ
    J Affect Disord; 2006 Jul; 93(1-3):259-63. PubMed ID: 16677715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.
    Muhtz C; Wester M; Yassouridis A; Wiedemann K; Kellner M
    J Psychiatr Res; 2008 Jul; 42(8):689-93. PubMed ID: 17884095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.